Wiley-Blackwell To Publish Journal Of Diabetes Investigation
Main Category: DiabetesArticle Date: 31 Jul 2009 - 1:00 PDT
| Patient / Public: | ![]() |
2 (1 votes) |
| Healthcare Prof: | ![]() |
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc (NYSE: JWa), (NYSE: JWb), has announced that it will be publishing a new diabetes journal titled Journal of Diabetes Investigation from 2010.
Published bi-monthly, the official journal of the Asian Association for the Study of Diabetes (AASD), Journal of Diabetes Investigation will publish both basic and clinical research in diabetes - including a variety of original research, country reports, commentaries, reviews; mini-reviews case reports letters as well as editorials and news.
The President of the AASD, Professor Yutaka Seino, said, "The rapid increase in the number of diabetes patients will dramatically impact the medical profession in Asia and will require increasing research on the disease specifically among Asians. The AASD will aggressively promote research activity with the aim of promptly improving diabetes treatments and care for a vast number of Asian patients."
The Editor-in-chief of the journal, Nigishi Hotta, said, "The journal will have an international editorial team of experts from the AASD countries and beyond, and will embrace clinical and experimental research in diabetes and its related areas - including aspects of prevention, treatment, education, nutrition, metabolic risk, psychosocial and socio-economic research, as well as molecular aspects and pathophysiology. We seek to develop Journal of Diabetes Investigation to position it as the core diabetes journal of Asia. Wiley-Blackwell, with its international publishing expertise and experience of publishing in cooperation with medical societies in Asia, is the ideal partner to enable the editorial board to meet its goals."
The President of the Japan Diabetes Society, Professor Takashi Kadowaki, added, "We are delighted to be publishing with Wiley-Blackwell and look forward to working with the team to communicate ground- breaking research and exciting discoveries to the world's research communities and health care professionals."
The Medical Editorial Director of Wiley-Blackwell, Neil Christensen, remarked, "The significant society involvement - in addition to an editorial board of such high caliber - will make this a project to be reckoned with in terms of authority. We're very well positioned to help the Journal of Diabetes Investigation realize its full potential and increase its visibility to readers both within North Asia as well as worldwide. The addition of this journal will also strengthen our position as a leading publisher of choice for societies and organizations focused on all aspects of diabetic health and endocrinology research. "
Source
Wiley-Blackwell
Visit our diabetes section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/159392.php>
APA
http://www.medicalnewstoday.com/releases/159392.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





